{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:04:28Z","timestamp":1792105468416,"version":"4.4.0"},"publisher-location":"New York, NY","reference-count":48,"publisher":"Springer New York","isbn-type":[{"value":"9781461434603","type":"print"},{"value":"9781461434610","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-4614-3461-0_4","type":"book-chapter","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T23:35:34Z","timestamp":1345332934000},"page":"44-55","source":"Crossref","is-referenced-by-count":5,"title":["Naturally Occurring Antibodies as Therapeutics for Neurologic Disease"],"prefix":"10.1007","author":[{"given":"Arthur E.","family":"Warrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Van Keulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry R.","family":"Pease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"4_CR1","first-page":"117","volume":"216","author":"S. Lacroix-Desmazes","year":"1998","unstructured":"Lacroix-Desmazes S, Kaveri SV, Mouthon L et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J ImmunolMethods 1998; 216:117\u201337. PMID:9760219 doi:10.1016\/S0022-1759(98)00074-X","journal-title":"J ImmunolMethods"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","volume":"7","author":"A. Coutinho","year":"1995","unstructured":"Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995; 7:812\u20138. PMID:8679125 doi:10.1016\/0952-7915(95)80053-0","journal-title":"Curr Opin Immunol"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/ncpneuro0376","volume":"3","author":"R. Gold","year":"2007","unstructured":"Gold R, Stangel M, Dalakas MC. Drug Insight: the use of intravenous immunoglobulin in neurology-therapeutic considerations and practical issues. Nat Clin Pract Neurol 2007; 3:36\u201344. PMID: 17205073 doi:10.1038\/ncpneuro0376","journal-title":"Nat Clin Pract Neurol"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"J.H. Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M et al. Multiple sclerosis. N Engl J Med 2000; 343:938\u201352. PMID: 11006371 doi:10.1056\/NEJM200009283431307","journal-title":"N Engl J Med"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0140-6736(96)09377-4","volume":"349","author":"F. Fazekas","year":"1997","unstructured":"Fazekas F, Deisenhammer F, Strasser-Fuchs S et al. Randomisedplacebo-controlledtrial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group. Lancet 1997; 349:589\u201393. PMID:9057729 doi:10.1016\/S0140-6736(96)09377-4","journal-title":"Lancet"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.50.5.1273","volume":"50","author":"P.S. Sorensen","year":"1998","unstructured":"Sorensen PS, Wanscher B, Jensen CV et al. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis. Neurology 1998; 50:1273\u201381. PMID:9595974","journal-title":"Neurology"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1191\/1352458505ms1224oa","volume":"11","author":"J. Haas","year":"2005","unstructured":"Haas J, Maas-Enriquez M, Hartung HP. Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis-results of a retrospective multicenter observational study over five years. Mult Scler 2005; 11:562\u20137. PMID:16193894 doi:10.1191\/1352458505ms 1224oa","journal-title":"Mult Scler"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000318281.98220.6f","volume":"71","author":"F. Fazekas","year":"2008","unstructured":"Fazekas F, Lublin FD, Li D et al. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology 2008; 71:265\u201371. PMID: 18645164 doi: 10.1212\/01.wnl.0000318281.98220.6f","journal-title":"Neurology"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(04)17101-8","volume":"364","author":"O.R. Hommes","year":"2004","unstructured":"Hommes OR, Sorensen PS, Fazekas F et al. Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial. Lancet 2004; 364:1149\u201356. PMID:15451222 doi:10.1016\/S0140-6736(04)17101-8","journal-title":"Lancet"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/jnnp.55.9.747","volume":"55","author":"W.I. McDonald","year":"1992","unstructured":"McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 1992; 55:747\u201352. PMID:1402963 doi:10.1136\/jnnp.55.9.747","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1212\/WNL.56.11.1514","volume":"56","author":"J.H. Noseworthy","year":"2001","unstructured":"Noseworthy JH, O\u2019Brien PC, Petterson TM et al. A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology 2001; 56:1514\u201322. PMID: 11402108","journal-title":"Neurology"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","volume":"64","author":"H.G. Roed","year":"2005","unstructured":"Roed HG, Langkilde A, Sellebjerg F et al. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. Neurology 2005; 64:804\u201310. PMID:15753413 doi:10.1212\/01. WNL.0000152873.82631.B3","journal-title":"Neurology"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1212\/WNL.55.8.1135","volume":"55","author":"J.H. Noseworthy","year":"2000","unstructured":"Noseworthy JH, O\u2019Brien PC, Weinshenker BG et al. IV immunoglobulin does not reverse established weakness in MS. Neurology 2000; 55:1135\u201343. PMID:11071491","journal-title":"Neurology"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/j.1468-1331.2008.02258.x","volume":"15","author":"A. Tselis","year":"2008","unstructured":"Tselis A, Perumal J, Caon C et al. Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin. Eur J Neurol 2008; 15:1163\u20137. PMID:18727675 doi:10.1111\/j.1468-1331.2008.02258.x","journal-title":"Eur J Neurol"},{"key":"4_CR15","first-page":"325","volume":"7","author":"M. Rodriguez","year":"1987","unstructured":"Rodriguez M, Oleszak E, Leibowitz J. Theiler\u2019s murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol 1987; 7:325\u201365. PMID:2827957","journal-title":"Crit Rev Immunol"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/brain\/123.3.519","volume":"123","author":"D.B. McGavern","year":"2000","unstructured":"McGavern DB, Murray PD, Rivera-Quinones C et al. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 2000; 123:519\u201331. PMID:10686175 doi:10.1093\/brain\/123.3.519","journal-title":"Brain"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P","volume":"58","author":"D.B. McGavern","year":"1999","unstructured":"McGavern DB, Murray PD, Rodriguez M. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. J Neurosci Res 1999; 58:492\u2013504. PMID:10533042 doi:10.1002\/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P","journal-title":"J Neurosci Res"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/exnr.1999.7082","volume":"158","author":"D.B. McGavern","year":"1999","unstructured":"McGavern DB, Zoecklein L, Drescher KM et al. Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp Neurol 1999; 158:171\u201381. PMID:10448429 doi:10.1006\/exnr.1999.7082","journal-title":"Exp Neurol"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00005072-198701000-00008","volume":"46","author":"M. Rodriguez","year":"1987","unstructured":"Rodriguez M, Lennon VA, Benveniste EN et al. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol 1987; 46:84\u201395. PMID:2432195 doi: 10.1097\/00005072-198701000-00008","journal-title":"J Neuropathol Exp Neurol"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ana.410270104","volume":"27","author":"M. Rodriguez","year":"1990","unstructured":"Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 1990; 27:12\u20137. PMID:2301922 doi:10.1002\/ana.410270104","journal-title":"Ann Neurol"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0896-6273(00)81118-6","volume":"24","author":"D.W. Huang","year":"1999","unstructured":"Huang DW, McKerracher L, Braun PE et al. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 1999; 24:639\u201347. PMID: 10595515 doi:10.1016\/S0896-6273(00)81118-6","journal-title":"Neuron"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0969-9961(02)00013-X","volume":"12","author":"B. Ellezam","year":"2003","unstructured":"Ellezam B, Bertrand J, Dergham P et al. Vaccination stimulates retinal ganglion cell regeneration in the adult optic nerve. Neurobiol Dis 2003; 12:1\u201310. PMID:12609484 doi:10.1016\/S0969-9961(02)00013-X","journal-title":"Neurobiol Dis"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1523\/JNEUROSCI.14-10-06230.1994","volume":"14","author":"D.J. Miller","year":"1994","unstructured":"Miller DJ, Sanborn KS, Katzmann JA et al. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 1994; 14:6230\u20138. PMID:7931575","journal-title":"J Neurosci"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<273::AID-JNR2>3.0.CO;2-G","volume":"43","author":"K. Asakura","year":"1996","unstructured":"Asakura K, Miller DJ, Murray K et al. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res 1996; 43:273\u201381. PMID:8714516 doi:10.1002\/(SICI)1097-4547(19960201)43:3<273::AID-JNR2>3.0.CO;2-G","journal-title":"J Neurosci Res"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/jnr.490330218","volume":"33","author":"A.E. Warrington","year":"1992","unstructured":"Warrington AE, Pfeiffer SE. Proliferation and differentiation of O4+ oligodendrocytes in postnatal rat cerebellum: analysis in unfixed tissue slices using anti-glycolipid antibodies. J Neurosci Res 1992; 33:338\u201353. PMID:1453495 doi:10.1002\/jnr.490330218","journal-title":"J Neurosci Res"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1523\/JNEUROSCI.18-19-07700.1998","volume":"18","author":"K. Asakura","year":"1998","unstructured":"Asakura K, Miller DJ, Pease LR et al. Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination. JNeurosci 1998; 18:7700\u20138. PMID:9742140","journal-title":"JNeurosci"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0169-328X(95)00190-4","volume":"34","author":"K. Asakura","year":"1995","unstructured":"Asakura K, Miller DJ, Pogulis RJ et al. Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes. Brain Res Mol Brain Res 1995; 34:283\u201393. PMID:8750831 doi:10.1016\/0169-328X(95)00190-4","journal-title":"Brain Res Mol Brain Res"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jaut.2007.07.010","volume":"29","author":"S. Avrameas","year":"2007","unstructured":"Avrameas S, Ternynck T, Tsonis IA et al. Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 2007; 29:213\u20138. PMID:17888629 doi:10.1016\/j.jaut.2007.07.010","journal-title":"J Autoimmun"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1073\/pnas.97.12.6820","volume":"97","author":"A.E. Warrington","year":"2000","unstructured":"Warrington AE, Asakura K, Bieber AJ et al. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci USA 2000; 97:6820\u20135. PMID: 10841576 doi:10.1073\/pnas.97.12.6820","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4049\/jimmunol.128.1.24","volume":"128","author":"N.A. Brown","year":"1982","unstructured":"Brown NA, Miller G. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus. J Immunol 1982; 128:24\u20139. PMID:6274955","journal-title":"J Immunol"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1096\/fj.01-0994fje","volume":"16","author":"Y. Mitsunaga","year":"2002","unstructured":"Mitsunaga Y, Ciric B, Van Keulen V et al. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J 2002; 16:1325\u20137. PMID:12154009","journal-title":"FASEB J"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/glia.10033","volume":"37","author":"A.J. Bieber","year":"2002","unstructured":"Bieber AJ, Warrington A, Asakura K et al. Human antibodies accelerate the rate of remyelination following lysolecithin-induceddemyelinationin mice. Glia 2002; 37:241\u20139. PMID:1 1857682 doi:10.1002\/glia.10033","journal-title":"Glia"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/jnr.21217","volume":"85","author":"A.E. Warrington","year":"2007","unstructured":"Warrington AE, Bieber AJ, Ciric B et al. A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res 2007; 85:967\u201376. PMID:17304578 doi:10.1002\/jnr.21217","journal-title":"J Neurosci Res"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1096\/fj.04-2026fje","volume":"18","author":"I. Pirko","year":"2004","unstructured":"Pirko I, Ciric B, Gamez J et al. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J 2004; 18:1577\u20139. PMID:15319372","journal-title":"FASEB J"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0022-510X(97)00080-4","volume":"150","author":"S.F. Hunter","year":"1997","unstructured":"Hunter SF, Miller DJ, Rodriguez M. Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. J Neurol Sci 1997; 150:103\u201313. PMID:9268236 doi:10.1016\/S0022-510X(97)00080-4","journal-title":"J Neurol Sci"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.expneurol.2007.05.005","volume":"206","author":"W.A. Banks","year":"2007","unstructured":"Banks WA, Farr SA, Morley JE et al. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer\u2019s disease: an age-related selective uptake with reversal of learningimpairment. Exp Neurol 2007; 206:248\u201356. PMID:17582399 doi:10.1016\/j.expneurol.2007.05.005","journal-title":"Exp Neurol"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1044-7431(02)00018-0","volume":"22","author":"M.M.P. Sold\u00e1n","year":"2003","unstructured":"Paz Sold\u00e1n MM, Warrington AE, Bieber AJ et al. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci 2003; 22:14\u201324. PMID:12595235 doi:10.1016\/S1044-7431(02)00018-0","journal-title":"Mol Cell Neurosci"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/glia.21048","volume":"58","author":"J. Watzlawik","year":"2010","unstructured":"Watzlawik J, Holicky E, Edberg DD et al. Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lynkinase in primary rat oligodendrocytes. Glia 2010; 58:1782\u201393. PMID:20645409 doi:10.1002\/glia.21048","journal-title":"Glia"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1750-3639.2003.tb00489.x","volume":"13","author":"B. Ciric","year":"2003","unstructured":"Ciric B, Howe CL, Paz Soldan M et al. Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol 2003; 13:608\u201316. PMID:14655764 doi:10.1111\/j.1750-3639.2003. tb00489.x","journal-title":"Brain Pathol"},{"issue":"Suppl 2","key":"4_CR40","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"H.W. Schroeder Jr.","year":"2010","unstructured":"Schroeder HW Jr., Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010; 125(Suppl 2):S41\u201352. PMID:20176268 doi:10.1016\/j.jaci.2009.09.046","journal-title":"J Allergy Clin Immunol"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nbd.2003.09.002","volume":"15","author":"C.L. Howe","year":"2004","unstructured":"Howe CL, Bieber AJ, Warrington AE et al. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis 2004; 15:120\u201331. PMID:14751777 doi:10.1016\/j.nbd.2003.09.002","journal-title":"Neurobiol Dis"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ana.10253","volume":"52","author":"R. Dodel","year":"2002","unstructured":"Dodel R, Hampel H, Depboylu C et al. Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer\u2019s disease. Ann Neurol 2002; 52:253\u20136. PMID: 12210803 doi:10.1002\/ana.10253","journal-title":"Ann Neurol"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1136\/jnnp.2003.033399","volume":"75","author":"R.C. Dodel","year":"2004","unstructured":"Dodel RC, Du Y, Depboylu C et al. Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 2004; 75:1472\u20134. PMID:15377700 doi:10.1136\/jnnp.2003.033399","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neurobiolaging.2004.06.008","volume":"26","author":"V. Geylis","year":"2005","unstructured":"Geylis V, Kourilov V, Meiner Z et al. Human monoclonal antibodies against amyloid-beta from healthy adults. Neurobiol Aging 2005; 26:597\u2013606. PMID:15708434 doi:10.1016\/j.neurobiolaging.2004.06.008","journal-title":"Neurobiol Aging"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.autrev.2008.03.007","volume":"7","author":"P. Szabo","year":"2008","unstructured":"Szabo P, Relkin N, Weksler ME. Natural human antibodies to amyloid beta peptide. Autoimmun Rev 2008; 7:415\u201320. PMID:18558354 doi:10.1016\/j.autrev.2008.03.007","journal-title":"Autoimmun Rev"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D. Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400:173\u20137. PMID:10408445 doi:10.1038\/22124","journal-title":"Nature"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F. Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6:916\u20139. PMID:10932230 doi:10.1038\/78682","journal-title":"Nat Med"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"e13928","DOI":"10.1371\/journal.pone.0013928","volume":"5","author":"M. Lindhagen-Persson","year":"2010","unstructured":"Lindhagen-Persson M, Brannstrom K, Vestling M et al. Amyloid-beta oligomer specificity mediated by the IgM isotype-implications for a specific protective mechanism exerted by endogenous auto-antibodies. PLoS ONE 2010; 5:e13928. PMID:21085663 doi:10.1371\/journal.pone.0013928","journal-title":"PLoS ONE"}],"container-title":["Advances in Experimental Medicine and Biology","Naturally Occurring Antibodies (NAbs)"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-3461-0_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T10:33:28Z","timestamp":1687689208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-3461-0_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781461434603","9781461434610"],"references-count":48,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-3461-0_4","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}